Zsírmáj (MASLD/MASH): nyitott vizsgálatok itt: Olaszország
33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- Bologna, Florence, Milan, Padova, Palermo, Rome
- Age
- 18 év to 75 év
- People
- 360 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07631637EU 2026-525916-33-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Bologna, Foggia, Messina, Milan, Modena, Naples, Novara, Roma, Rozzano, San Giovanni Rotondo, Torino
- Age
- 18 év to 80 év
- People
- 1650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Bologna, Foggia, Milan, Modena, Novara, Palermo, Rome, Rozzano, San Giovanni Rotondo, Turin, Verona
- Age
- 18 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444EU 2024-513739-25-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Bologna, Foggia, Milan, Modena, Palermo, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457EU 2024-513741-36-00Regiszter frissítve: 2026-10-28
3. fázisToborozResearch participation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- Bologna, Catania, Foggia, Messina, Milan, Modena, Novara, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 év and over
- People
- 205 worldwide
- Run by
- Akero Therapeutics Inc.
See details and how to join2024-512895-36-00EU 2024-512895-36-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Rome, Rozzano, Turin
- Age
- 18 év to 80 év
- People
- 1350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169EU 2023-509912-27-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Bergamo, Foggia, Milan, Novara, Palermo, Rome, Rozzano, Turin
- Age
- 18 év to 75 év
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374EU 2023-510395-31-00Regiszter frissítve: 2026-10-23
3. fázisToborzás még nem indultResearch participation
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
- Where
- Bergamo, Bologna, Foggia, Milan, Padova, Rome, Rozzano
- Age
- 18 év and over
- People
- 382 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2026-525755-82-00EU 2026-525755-82-00Regiszter frissítve: 2026-10-19
3. fázisToborzás még nem indultResearch participation
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
- Where
- Bergamo, Bologna, Foggia, Milan, Padova, Rome, Rozzano
- Age
- 18 év and over
- People
- 69 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2026-525757-37-00EU 2026-525757-37-00Regiszter frissítve: 2026-10-19
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Bologna, Catania, Foggia, Messina, Milan, Modena, Novara, Roma, Rozzano, San Giovanni Rotondo, Torino
- Age
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314Regiszter frissítve: 2026-10-13
3. fázisToborozTrial-stage medicine
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Bergamo, Bologna, Florence, Milan, Naples, Padova, Palermo, Roma, Rome, Rozzano, Torino, Verona
- Age
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028EU 2025-522674-36-00Regiszter frissítve: 2026-10-08
No phaseToborozResearch participation
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
- Where
- Rome
- Age
- 18 év and over
- People
- 252
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06879236Regiszter frissítve: 2026-09-17
3. fázisToborozTrial-stage medicine
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- Where
- Ancona, Bergamo, Bologna, Florence, Foggia, Milan, Padova, Rome, Rozzano, Turin
- Age
- 18 év to 75 év
- People
- 1250 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07221188EU 2025-523674-16-00Regiszter frissítve: 2026-09-17
4. fázisToborozTrial-stage medicine
Fibrosis Lessens After Metabolic Surgery
- Where
- Milan, Roma
- Age
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875Regiszter frissítve: 2026-07-31
No phaseToborzás még nem indultResearch participation
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach
- Where
- Castellana Grotte
- Age
- 18 év and over
- People
- 24
- Run by
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
See details and how to joinNCT07644936Regiszter frissítve: 2026-07-15
No phaseToborozResearch participation
UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers
- Where
- Roma
- Age
- 18 év and over
- People
- 450 worldwide
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT07652151Regiszter frissítve: 2026-06-23
No phaseToborozResearch participation
EVOO and Metabolic Liver Health in MASLD
- Where
- Castellana Grotte
- Age
- 18 év to 65 év
- People
- 60
- Run by
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
See details and how to joinNCT07412444Regiszter frissítve: 2026-05-06
No phaseToborozResearch participation
Liver Steatosis in Pediatric CD Patients
- Where
- Palermo
- Age
- 1 év to 14 év
- People
- 91
- Run by
- University of Palermo
See details and how to joinNCT06206616Regiszter frissítve: 2026-05-01
No phaseToborozResearch participation
Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD
- Where
- Castellana Grotte
- Age
- 18 év to 65 év
- People
- 90
- Run by
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
See details and how to joinNCT06186869Regiszter frissítve: 2026-03-27
No phaseToborozResearch participation
Spleen Stiffness Measurement for the Detection of Advanced Fibrosis
- Where
- Rome
- Age
- 18 év and over
- People
- 500
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07440511Regiszter frissítve: 2026-02-27
3. fázisToborozResearch participation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Bologna, Foggia, Messina, Milan, Modena, Naples, Novara, Pisa, Rome, Rozzano, San Giovanni Rotondo, Turin
- Age
- 18 év and over
- People
- 244 worldwide
- Run by
- Akero Therapeutics Inc.
See details and how to join2023-505141-48-00EU 2023-505141-48-00Regiszter frissítve: 2026-01-22
No phaseToborozResearch participation
Evaluation of Risk of hEpatocellular Carcinoma
- Where
- Milan
- Age
- 45 év to 75 év
- People
- 500
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT06523179Regiszter frissítve: 2025-11-20
No phaseToborozTrial-stage medicine
Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)
- Where
- Milan
- Age
- 18 év and over
- People
- 60
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT06856252Regiszter frissítve: 2025-11-20
No phaseToborozResearch participation
The Liver BIoBank Lombardia of Fatty Liver
- Where
- Milan
- Age
- 40 év to 60 év
- People
- 2500
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT06566105Regiszter frissítve: 2025-11-18
No phaseToborzás még nem indultResearch participation
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
- Where
- Turin
- Age
- 18 év and over
- People
- 30 000 worldwide
- Run by
- Universität des Saarlandes
See details and how to joinNCT06907563Regiszter frissítve: 2025-04-02
Minden vizsgálat (Zsírmáj (MASLD/MASH)) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.